0035

Inpatient A

  1.        

Aarsland A, Wolfe RR.  Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men.  J Lipid Res 39:1280-1286, 1998.

 4.139

0103

Outpatient A

      2.    

Abdel-Rahman S, Salama AS, Au WW, Hamada FA. The role of polymorphic CYP2E1 and CYP2D6 genes in NNK-induced chromosome aberrations in cultured human lymphocytes.  Pharmacogenetics 10:239-249, 2000.

 4.371

0033

*Outpatient A

      3.    

Abdel-Rahman SZ, Ammenheuser MM, Ward JB Jr. Human sensitivity to 1,3-butadiene: role of microsomal epoxide hydrolase polymorphisms.  Carcinogenesis 22:415-426, 2001.

 4.543

0033

*OutpatientA

      4.    

Abdel-Rahman SZ, El-Zein RA, Ammenheuser MM, Yang Z, Stock TH, Morandi M, Ward JB Jr.  Variability in human sensitivity to 1,3-butadiene: Influence of the allelic variants of the microsomal epoxide hydrolase gene.  Environ Mol Mutagen 41:140-146, 2003.

 2.546

0009

Outpatient A

      5.    

Acosta PB, Yannicelli S, Singh R, Mofidi S, Steiner R, DeVincentis E, Jurecki E, Bernstein L, Gleason S, Chetty M, Rouse B.  Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy.  J Am Diet Assoc  103;1167-1173, 2003.

 1.483

0027

*Outpatient A

      6.    

Alarcon GS, Friedman AW, Straaton KV, Moulds JM, Lisse J, Bastian HM, McGwin G, Bartolucci AA, Roseman JM, Reveille JD.  Systemic lupus erythematosus in three ethnic groups: III A comparison of characteristics early in the natural history of the LUMINA cohort.  Lupus 8:197-209, 1999.

 1.875

0027

*Outpatient A

      7.    

Alarcon GS, McGwin G, Bastian HM, et al.  Systemic lupus erythematosus in three ethnic groups, the lumina study: VII. Predictors of early mortality.  Arthritis Rheum 45:191-202, 2001.

 7.389

0027

Outpatient A

      8.    

Alarcón GS, McGwin G, Jr, Bartolucci A, Roseman IM, Baethge B, Fessler B, Bastian HM, Friedman A W, Reveille JD for the LUMINA Study Group.  Systemic lupus erythematosus in three ethnic groups, the Lumina Study: IX. Differences in damage accrual.  Arthritis Rheum 44:2797-2806, 2001.

 7.389

0027

Outpatient A

      9.    

Alarcón GS, Rodríguez JL, Benavides G, Jr, Brooks K, Kurusz H, Reveille JD.  Systemic lupus erythematosus in three ethnic groups: V. Acculturation, health-related attitudes and behaviors and disease activity in Hispanic patients from the LUMINA cohort.  Arthritis Care Res 12:267-274, 1999.

 1.068

0027

Outpatient A

    10.  

Alarcón GS, Roseman J, Bartolucci AA, Friedman AW, Moulds JM, Goel N, Straaton KV, Reveille JD.  Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course.  Arthritis Rheum 41:1173-1180, 1998.

 7.389

0259

*Outpatient A

    11.  

Aljubeh JM, Miller AL, Meyer III WJ, Thompson, EB. Glucocorticoid receptor characteristics in normal children Æs leukocytes: Correlation with gender, weight, age and plasma.  Cortisol J Pedi Endo 14 :1641-1647, 2001.

 Not Available

0071

Outpatient A

    12.  

Alshanti M, Eledrisi MS, Jones E.  Rhabdomyolysis associated with hyperthyroidism.  Am J Emer Med 19:317, 2001.

1.133

0080

*Outpatient A

    13.  

Alter BP, Caruso JP, Drachtman RA, Uchida T, Velagaleti GV, Elghetany MT.  Fanconi anemia:  Myelodysplasia as a predictor of outcome.  Cancer Genet Cytogenet 117:125-131, 2000.

1.529

0033

Outpatient A

    14.  

Ammenheuser MM, Bechtold WE, Abdel-Rahman SZ, Rosenblatt JI, Hastings-Smith DA, Ward JB Jr.  Assessment of 1,3-butadiene exposure in polymer production workers using hprt mutation in lymphocytes as a biomarker.  Environ Health Persp 109:1249-1255, 2001.

3.137

0103

Outpatient A

    15.  

Au WW, Sierra-Torres HC, Cajas-Salazar N, Salama AS.  Inheritance of polymorphic metabolizing genes on environmental disease and on quality of life.  Mutat Res 428:131-140, 1999.

2.545

0103

Outpatient A

    16.  

Au WW, Anwar W, Sram RJ, Chulasiri M, Ribeiro L.  International conferences on environmental mutagens in human populations – opportunities, accomplishments and challenges.  Monographs published in Mutat Res 428:1-376, 1999.

2.545

0103

Outpatient A

    17.  

Au WW, Badary OA, Heo MY.  Cytogenetic assays for monitoring populations exposed to environmental mutagens.  Occ Med 16:345-57, 2001.

1.973

0103

Outpatient A

    18.  

Au WW, Oberheitmann B, Heo MY, Hoffmann W, Oh HY.  Biomarker monitoring for health risk based on sensitivity to environmental mutagens.  Rev on Environ Health 16:41-64, 2001.

Not Available

0103

Outpatient A

    19.  

Au WW, Oh HY, Grady J, Salama S, Heo MY.  Usefulness of genetic susceptibility and biomarkers for evaluation of environmental health risk.  Environ Mol Mutag 37 :215-225, 2001.

2.276

0103

*

    20.  

Au WW, Oh HY, Salama S, Kietthubthew S.  Genetic susceptibility to environmental disease.  Life Sciences 313:312-318, 2000.

1.758

0103

Outpatient A

    21.  

Au WW, Sierra-Torres H, Cajas-Salazar N, Shipp BK, Legator MS. Cytogenetic effects from exposure to mixed pesticides and the influence from genetic susceptibility.  Environ Health Persp 107:501-505, 1999.

3.137

0103

Outpatient A

    22.  

Au WW. Susceptibility of children to environmental toxic substances.  Int J Hyg Environ Health 205:501-503, 2002.

0.480

0103

Outpatient A

    23.  

Au WW.  Lifestyle factors and acquired susceptibility to environmental disease.  Int J Hygiene and Env Health 204:17 – 22, 2001.

0.480

0103

*Outpatient A

    24.  

Au WW, Salama  SA, Sierra-Torres CH. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Persp 111:1843-1850, 2003.

3.452

0072

Inpatient A

    25.  

Bamman MM, Shipp JR, Jiang J, Gower BA, Hunter GR, Goodman A, McLafferty Jr CL, Urban RJ.  Mechanical load increases muscle IGF-I and androgen receptor mRNA concentrations in humans.  Am J Physiol Endocrinol Metab 280:E383-E390, 2001.

3.324

0069

*Outpatient A

    26.  

Baima J, Nicolaou M, Schwartz F, DeStefano AL, Manolis A, Garvas I, Laffer CL, Elijovick F, Farrer L, Baldwin CT, Gavras H. Evidence for linkage between essential hypertension and a putative locus on human chromosome 17.  Hypertension 34:4-7, 1999.

5.364

0320

Outpatient A

    27.  

Baron S, Poast J, Richardson CJ, Nguyen D, Cloyd MW.  Oral transmission of human immunodeficiency virus by infected seminal fluid and milk: a novel mechanism.  J Infect Dis 181: 498-504, 2001.

4.910

0018

0307

Inpatient A

    28.  

Barone GW, Gurley BJ, Anderson KE, Ketel BL, Abul-Ezz SR.  The tolerability of newer immunosuppressive medications in a patient with acute intermittent porphyria.  J Clin Pharmacol 41:113-115, 2001.

2.167

0096

0343

Inpatient A

    29.  

Barret JP, Dziewulski P, Wolf SE, Desai MH, Herndon DN.  Effects of recombinant human growth hormone on burn scar development.  Plast Reconstr Surg 104:726-729, 1999.

1.436

0027

Outpatient A

    30.  

Bastian HM, Roseman JM, McGwin G, Jr, Alarcón GS, Friedman AW, Fessler BJ, Baethge BA, Reveille JD for the LUMINA Study Group.  Systemic lupus erythematosus in three ethnic groups XII: Risk factors for lupus nephritis after diagnosis.  Lupus 11:152-160, 2002.

1.875

0016

*Outpatient A

    31.  

Berenson AB, Chacko MR, Wiemann CM, et al.  Use of hymenal measurements in the diagnosis of previous penetration.  Pediatrics 109:228-235, 2002.

3.708

0016

*Outpatient A

    32.  

Berenson AB, Chacko MR, Wiemann CM, Mishaw CO, Friedrich WN, Grady JJ.  A case-control study of anatomic changes resulting from sexual abuse.  Am J Obstet Gynecol 182:820-831, 2000.

2.871

0016

*Outpatient A

    33.  

Berenson AB, Grady JJ.  A longitudinal study of hymenal development from 3 to 9 years of age.  J Pediatr 140:600-607, 2002.

3.536

0302

Outpatient A

    34.  

Berenson AB, Radecki CM, Grady JJ, Rickert VI, Thomas A.  A prospective, controlled study of the effects of hormonal contraception on bone mineral density.  Obstet Gynecol 98:576-582, 2001.

2.196

0011

Inpatient A

    35.  

Biolo G, Williams BD, Fleming RY, Wolfe RR.  Insulin action on muscle protein kinetics and amino acid transport during recovery after resistance exercise.  Diabetes 48:949-957, 1999.

7.700

0011

*Inpatient A

    36.  

Bohe J, Low A, Wolfe RR, Rennie MJ.  Latency and duration of stimulation of human muscle protein synthesis during continuous infusion of amino acids.  J Physiol 532:575-579, 2001.

4.476

0011

*Inpatient A

    37.  

Bohe J, Low A, Wolfe RR, Rennie MJ.  Human muscle protein synthesis is modulated by extracellular, not intramuscular amino acid availability: a dose-response study.  J Physio 552:315-24, 2003.

4.650

0103

Outpatient A

    38.  

Bonassi S, Au WW.  Biomarkers in molecular epidemiology studies for health risk prediction.  Mutat Res 511:73-86, 2002.

2.545

0258

Inpatient A

    39.  

Borsheim E, Tipton KD, Wolf SE, Wolfe RR.  Essential amino acids and muscle protein recovery from resistance exercise.  Am J Physiol: Endocrinol Metabol 283:E648-E657, 2002.

3.324

0345

*Inpatient A

Outpatient A

    40.  

Børsheim E, Cree M, Tipton KD, Elliot TA, Aarsland A, Wolfe RR.  Effect of carbohydrate intake on net muscle protein synthesis during recovery from resistance exercise.  J Appl Physiol Accepted 08/01/2003, 2004.

2.720

0287

*Inpatient A

Outpatient A

    41.  

Børsheim E, Aarsland A, Wolfe RR.  Effect of an amino acid, protein, and carbohydrate mixture on net muscle protein balance after resistance exercise.  Int J Sports Nutr Ex Metab 2004. Accepted 10/01/2003.

0.857

0347

Outpatient A

    42.  

Button B, Reuss L, Altenberg GA.  PKC-mediated stimulation of amphibian CFTR depends on a single phosphorylation consensus site.  Insertion of this site confers PKC sensitivity to human CFTR.  J Gen Physiol 117:457-467, 2001.

5.477

0076

*Inpatient A

    43.  

Cajas-Salazar N, Au WW, Zwischenberger JB, Sierra-Torres CH, Salama SA, Alpard SK, Tyring SK. Effect of epoxide hydrolase polymorphisms on chromosome aberrations and risk for lung cancer.  Cancer Genet Cytogenet 145:97-102, 2003.

1.713

0076

*Inpatient A

    44.  

Cajas-Salazar N,  Sierra-Torres CH,  Salama SA,  Zwischenberger JB,  Au WW.  Combined effect of MPO, GSTM1 and GSTT1 polymorphisms on chromosome aberrations and lung cancer risk.  Int J Hyg Environ Health 206:473-83, 2003.

0.901

0082

Outpatient A

    45.  

Canafax DM, Yuan, Z, Chonmaitree T, Deka K, Russlie HQ, Giebink GS.  Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media.  Pediatr Infect Dis J 17:149-56,1998.

2.289

0073

0074

Inpatient A

    46.  

Cao S, Hudnall SD, Kohan F, Lu, LJW.  Measurement of estrogen receptors in intact cells by flow cytometry.  Cytometry 41:109-114, 2000.

2.220

0320

Outpatient A

    47.  

Chen J, Wang L, Chen JJ, Sahu GK, Tyring S, Ramsey K, Indrikovs AJ, Petersen JR, Paar D, Cloyd MW.  Detection of antibodies to human immunodeficiency virus (HIV) that recognize conformational epitopes of glycoproteins 160 and 41 often allows for early diagnosis of HIV infection.  J Infect Dis 186:321-331, 2002.

4.910

0082

Outpatient A

    48.  

Chonmaitree T, Henrickson KJ.  Detection of respiratory viruses in the middle ear fluids of children with acute otitis media by multiplex reverse transcription-polymerase chain reaction assay.  Pediatr Infect Dis J 19: 258-60, 2000.

2.289

0082

Outpatient A

    49.  

Chonmaitree T.  Viral and bacterial interaction in acute otitis media.  Review, Pediatr Infect Dis J, 19: S24-30, 2000.

2.289

0261

*Outpatient A

    50.  

Chonmaitree T, Saeed K, Uchida T, Heikkinen T, Baldwin CD, Freeman DH Jr, McCormick DP.  A randomized, placebo-controlled trial of the effect of antihistamine or corticosteroid treatment in acute otitis media.  J Pediatr 143:377-85, 2003.

3.219

0261

*Outpatient A

    51.  

Chonmaitree T, Saeed KA, Uchida T, Heikkinen T, Baldwin CD, McCormick DP.  Effect of antihistamine and corticosteroid treatment in acute otitis media: a randomized clinical trial.  J Pediatrics 2004. Accepted 08/01/2003.

3.219

0096

0343

Inpatient A

    52.  

Chrysopoulo MT, Jeschke MG, Ramirez RJ, Barrow RE, Herndon DN.  Growth hormone attenuates tumor necrosis factor a in burned children.  Arch Surg 134:283-286, 1999.

2.792

0011

Inpatient A

    53.  

Coggan AR, Raguso CA, Gastaldelli A, Sidossis LS, Yeckel CW. Fat metabolism during high-intensity exercise in endurance-trained and untrained men.  Metabolism 49:122-128, 2000.

1.931

0244

*Outpatient A

    54.  

Copland JA, Davies PJ, Shipley GL, Wood CG, Luxon BA, Urban RJ.  The use of DNA microarrays to assess clinical samples: the transition from bedside to bench to bedside. Recent Prog Horm Res 58:25-53, 2003.

1.231

0096

0343

Outpatient A

    55.  

Cucuzzo N, Ferrando AA, Herndon DN.  The effects of exercise programming vs. traditional outpatient therapy in the rehabilitation of severely burned children.  J of Burn Care Rehab 22:214-220 2001.

0.752

0253

*Outpatient A

    56.  

deFilippi C, Wasserman S, Rosanio S, Tiblier E,Sperger H, Tocchi M,   Christenson R, Uretsky B, Smiley M, Gold J, Muniz H, Badalamenti J, Henrich W.  Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.  JAMA 290:353-359, 2003.

16.586

0260

*Inpatient A

Outpatient A

    57.  

Durham WJ, Yeckel CW, Miller SL, Gore DC, Wolfe RR. Exogenous nitric oxide increases basal leg glucose uptake in humans.  Metabolism 52:662-665, 2003.

2.009

0037

0018

*Inpatient A

Outpatient A

    58.  

Egger NG, Goeger DE, Payne DA, Miskovsky EP, Weinman SA, Anderson KE.  Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.  Dig Dis & Sci 47:419-426, 2002.

1.516

0071

Outpatient A

    59.  

Eledrisi M, Urban R, Lieberman S.  Brain injury and neuroendocrine dysfunction.  Endocrinologist 11:275-281, 2001.

0.474

0071

Outpatient A

    60.  

Eledrisi MS, Flesner K, Lieberman S.  Visual Vignette.  Endo Pract  6:5, 2000.

Not Available

0069

*Inpatient A

    61.  

Elijovich F, Laffer CL, Gavras H, Bresnahan MR, Schiffrin EL.  Regulation of plasma endothelin by salt in salt-sensitive hypertension.  Circulation 103:263-268, 2001.

10.517

0098

*Inpatient A

Outpatient A

    62.  

Ferrando AA.  Differential anabolic effects of testosterone and amino acid feeding in older men. J Clin Endocrinol Metab 88:358-362, 2003.

5.199

0098

*Inpatient A

Outpatient A

    63.  

Ferrando AA, Paddon-Jones D, Wolfe RR.  Alterations in protein metabolism during space flight and inactivity*1.  Nutrition 18(10):837-841, 2002.

2.272

0072

*Inpatient A

Outpatient A

    64.  

Ferrando AA, Sheffield-Moore M, Yeckel CW, Gilkison C, Jiang J, Marcell T, Achacosa A, Lieberman SA, Tipton K, Wolfe RR, Urban RJ.  Testosterone administration improves muscle function: Molecular and physiological mechanisms.  Am J Physiol: Endocrinol Metab 282:E601-E607, 2002.

3.324

0098

*Inpatient A

    65.  

Ferrando AA, Sheffield-Moore M, Wolf SE, Herndon DN, Wolfe RR.  Testosterone administration in severe burns ameliorates muscle catabolism.  Crit Care Med 29:1936-1942, 2001.

3.486

0098

Inpatient A

    66.  

Ferrando AA.  Effects of inactivity and hormonal mediators on skeletal muscle during recovery from trauma.  Curr Opin Clin Nutri Metab Care 3:171-175, 2000.

Not Available

0098

*

    67.  

Ferrando AA, Stuart CA, Sheffield-Moore M, Wolfe RR.  Inactivity amplifies the catabolic response of skeletal muscle to cortisol.  J Clin Endocrinol Metab 84:3515-3521, 1999.

5.160

0072

Outpatient A

    68.  

Ferrando AA, Tipton KD, Doyle D, Phillips SM, Cortiella J, Wolfe RR.  Testosterone injection stimulates net protein synthesis but not tissue amino acid transport.  Am J Physiol (EndocrinolMetab 38) 276:E864-E871, 1998.

3.324

0072

Outpatient A

    69.  

Ferrando AA, Tipton KD, Doyle D, Phillips SM, Cortiella J, Wolfe RR.  Testosterone stimulates protein synthesis but not amino acid transport in humans.  Am J Physiol Endocrinol Metabol 275: E864 – E871, 1998.

 3.324

0018

Inpatient A

    70.  

Frank J, Jugert FK, Merk HF, Kalka K, Goerz G, Anderson K, Bickers DR, Poh-Fitzpatrick MB, Christiano AM.  A spectrum of novel mutations in the protoporphyrinogen oxidase gene in 13 families with variegate porphyria.  J Invest Dermatol 116:821-823, 2001.

 4.645

0027

*Outpatient A

    71.  

Friedman AW, Alarcon GS, McGwin G, Straaton KV, Roseman J, Goel N, Reveille JD.  Systemic lupus erythematosus in three ethnic groups: IV.  Factors associated with self-reported functional outcome in a large cohort study.  Arthritis Care and Res 12:256-266, 1999.

 1.068

0318

Inpatient A

    72.  

Gardner AW, Killewich LA.  Lack of functional benefits following infrainguinal bypass in peripheral arterial occlusive disease patients.  Vasc Med 6:9-14, 2001.

 1.145

0243

*Outpatient A

    73.  

Garfield RE, Maul H, Maner W, Fittkow C, Olson G, Shi L, Saade G. Uterine and light-induced fluorescence in the management of term and preterm labor.  J Soc Gynecol Invest 9:265-275, 2002.

 2.440

0243

Outpatient A

    74.  

Garfield RE, Maul H, Shi L, Maner W, Fittkow C, Olson G, Saade GR.  Methods and devices for the management of term and preterm labor.  Ann NY Academy Sci 943:203-224, 2001

 1.593

0002

Inpatient A

    75.  

Gasic S, Nagamani M, Green, A, Urban RJ.  Troglitazone is a competitive inhibitor of 3b-hydroxysteroid-dehydrogenase enzyme.  Am J Obstet Gynecol 184:575-579, 2001.

 2.871

0018

Inpatient A

    76.  

Goeger DE, Hsie AW, Anderson KE.  Co-mutagenicity of coumarin (1,2-bensoprone) with aflatoxin B1 and human liver S9 in mammalian cells.  Food Chem Toxicol 37:581-589, 1999.

 1.598

0265

*Inpatient A

    77.  

Gore DC, Wolfe RR.  Glutamine supplementation fails to affect muscle protein kinetics in critically ill patients.  J Parenter Enteral Nutr 26:342-349, 2002.

 1.927

0265

Inpatient A

    78.  

Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE Desai M.  Association of hyperglycemia with increased mortality following severe burn injury.  J Trauma 51:540-544, 2001.

 1.531

0265

Outpatient A

    79.  

Gore DC, Ferrando, AA, Barnett J, Wolf SE, Desai M, Herndon DN, Goodwin C, Wolfe RR.  Influence of glucose kinetics on plasma lactate concentration and energy expenditure in severely burned patients.  J Trauma 49:673-678, 2000.

 1.531

0265

Inpatient A

    80.  

Gore DC, Chinkes DL, Hart DW, Wolf SE, Herndon DN, Sanford AP.  Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients.  Crit Care Med 30:2438-2442, 2002.

 3.486

0009

Outpatient A

    81.  

Güttler, Flemming, M.D., Ph.D.; Colleen Azen, M.S.; Per Guldberg, Ph.D.; Anne Romstad, Ph.D.; William B. Hanley, M.D.; Harvey Levy, M.D.; Reuben Matalon, M.D., Ph.D.; Bobbye Rouse, M.D.; Friedrich Trefz, M.D.; Felix de la Cruz, M.D., M.P.H.; Richard Koch, M.D.; Impact of the Phenylalanine Hydroxylase Gene on Maternal Phenylketonuria Outcome.  Pediatrics, 112:1530-1533, 2003.

 3.416

0009

Outpatient A

    82.  

Guttler F, Azen C, Gulberg P, Romstad A, Hanley W, Levy H, Matalon R, Rouse B, Trefz F, de la Cruz F, Koch R.  Relationship among genotype, biochemical phenotype and cognitive performance in females with phenylalanine hydroxylase deficiency: Report from the maternal PKU collaborative study.  Pediatrics 104:258-262, 1999.

 3.708

0096

0343

Outpatient A

    83.  

Hart DW, Herndon DN, Klein G, Lee SB, Celis M, Mohan S, Chinkes DL, Wolf SE.  Attenuation of post-traumatic muscle catabolism and osteopenia by long-term growth hormone therapy Ann Surg 233:827-834, 2001.

 6.674

0096

0343

Inpatient A

    84.  

Hart DW, Wolf SE, Chinkes DL, Lal SO, Beauford RB, Celis M, Wolfe RR, Herndon DN.  Anti-catabolic synergism between growth hormone and propranolol after burn.  Surg Forum 51:196-197, 2000.

 Not Available

0096

0343

Inpatient A

    85.  

Hart DW, Wolf SE, Mlcak R, Chinkes DL, Ramzy PI, Obeng MK, Wolfe RR, Herndon DN.  Persistence of muscle catabolism after severe burn.  Surgery 128:312-319, 2000.

2.615

0096

Inpatient A

    86.  

Hart DW, Wolf SE, Chinkes DL, Lal SO, Ramzy PI, Herndon DN.  Beta-blockade and growth hormone after burn.  Ann of Surg 236:450-456; discussion 456-457, 2002.

6.674

0281

Inpatient A

    87.  

Hart DW, Wolf SE, Herndon DN, Chinkes DL, Lal SO, Obeng MK, Beauford RB, Mlcak RT.  Energy expenditure and caloric balance after burn: Increased feeding leads to fat rather than lean mass accretion.  Ann Surg 235:152-61, 2002.

6.674

0343

0096

Inpatient A

    88.  

Hart DW, Wolf SE, Ramzy PI, Chinkes DL, Beauford RB, Ferrando AA, Wolfe RR, Herndon DN.  Anabolic effects of oxandrolone after severe burn.  Ann Surg 233:556-64, 2001.

6.674

0096

*Inpatient A

Outpatient A

    89.  

Hart DW, Wolf SE, Chinkes DL, Beauford RB, Mlcak RP, Heggers JP, Wolfe RR, Herndon DN.  Effects of early excision and aggressive enteral feeding on hypermetabolism, catabolism, and sepsis after severe burn.  J Trauma 54:7.55-64, 2003.

1.617

0230

Outpatient A

    90.  

Havlir DV, Tierney C, Friedland GH, Pollard RB, Smeaton T, Sommadossi JP, Fox L, Kessler H, Fife KH, Richman DD.  In vivo antagonism with zidovudine plus stavudine combination therapy.  J Infect Dis 182:321-325, 2000.

4.910

0236

Outpatient D

    91.  

Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, Paar D, Hudson L, Ward P, Mills RG.  Oseltamivir Study Group.  Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.  N Engl J Med 341:1336-43, 1999.

29.065

0071

Outpatient B

    92.  

Hayes VY, Urban RJ, Jiang J, Marcell TJ, Helgeson K, Mauras N.  Recombinant human (rh)GH and rhIGF-I diminish the catabolic effects of hypogonadism in man: Metabolic and molecular effects.  JCEM 86:2211-2219, 2001.

5.160

0322

*Outpatient A

    93.  

Heikkinen T, Chonmaitree T.  The importance of respiratory viruses in acute otitis media.  Clin Microbiol Rev 16:230-241, 2003.

10.321

0082

*Outpatient A

    94.  

Heikkinen T, Saeed KA, McCormick DP, Baldwin C, Reisner BS, Chonmaitree T.  A single intramuscular dose of ceftriaxone changes nasopharyngeal bacterial flora in children with acute otitis media.  Acta Paeditr 89:1316-1321, 2000.

1.582

0082

Outpatient A

    95.  

Heikkinen T, Chonmaitree T.  Increasing importance of viruses in acute otitis media.  Ann Med, 32:157-163, 2000.

2.818

0082

Outpatient A

    96.  

Heikkinen T, Chonmaitree T.  Viral-bacterial synergy in otitis media: Implications for management.  Curr Infect Dis Reports 2:154-9, 2000.

0.820

0082

Outpatient A

    97.  

Heikkinen T, Thint M, Chonmaitree T.  Prevalence of various respiratory viruses in the middle ear during acute otitis media.  N Eng J Med, 340:260-264, 1999.

29.065

0082

Outpatient A

    98.  

Heikkinen T, Shenoy M, Goldblum RM, Chonmaitree T.  Quantification of cytokines and inflammatory mediators in samples of nasopharyngeal secretions with unknown dilution.  Pediatr Res 45:230-234, 1999.

3.289

0082

Outpatient A

    99.  

Heikkinen T, Shenoy M, Goldblum RM, Chonmaitree T.  Free secretory component as a standardization protein for nasopharyngeal specimens from children with upper respiratory infection.  Acta Paediatr 88: 150-153, 1999.

1.582

0082

Outpatient A

  100.     

Heikkinen T, Ghaffer F, Okoradudu AO, Chonmaitree T.  Serum interleukin-6 in bacterial and nonbacterial acute otitis media.  Pediatrics 102:296-299, 1998.

3.708

0216

*Outpatient A

  101.     

Henke KG, Frantz DE, Kuna ST.  An oral elastic mandibular advancement device of obstructive sleep apnea.  Am J Respir Crit Care Med 161:420-425, 2000.

5.956

0216

*Outpatient A

  102.     

Henke KG, Grady JJ, Kuna ST.  Effect of nasal continuous positive airway pressure on neuropsychological function in sleep apnea-hypopnea syndrome: A randomized, placebo-controlled trial.  Am J Respir Crit Care Med 163:911-917, 2001.

5.956

0103

Outpatient A

  103.     

Heo MY, Sohn SJ, Au WW.  Antigenotoxicity of galangin as a cancer chemopreventive agent candidate.  Mutat Res 488:135-150, 2001.

2.545

0265

*Inpatient A

Outpatient A

  104.     

Herndon DN, Hart DW, Wolf SE, Chinkes DL, Wolfe RR.  Reversal of catabolism by beta-blockade after severe burns.  N Engl J Med 345:1223-1229, 2001.

29.065

0265

Inpatient A

  105.     

Hibbert JM, Sutherland Jr GB, Wright Jr LL, Wolfe LG, Wolfe KA, Gao SP, Gore DC, Abd-Elfattah AS.  Measurement of hemoglobin synthesis rate in vivo using a stable isotope method.  Anal Biochem 91:118-123, 2001.

Not Available

0079

Inpatient A

  106.     

Hoogerwerf  WA, Pasricha PJ. Pharmacologic therapy in treating achalasia.  Gastrointest Clin North Am 11:311-323, 2001.

2.581

0079

Inpatient A

  107.     

Hoogerwerf WA, Pasricha PJ.  Achalasia: treatment options revisited.  Can J Gastroenterol 14:406-409, 2000.

1.368

0079

Inpatient A

  108.     

Hoogerwerf WA, Pasricha PJ.  Botulinum toxin for spastic gastrointestinal disorders.  Baillieres Best Pract Res Clin Gastroenterol 13:131-143, 1999.

Not Available

0296

Inpatient A

  109.     

Ikeda M, Yi M, Li K, Lemon SM.  Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.  J Virol 76:2997-3006, 2002.

5.622

0096

0343

Inpatient A

  110.     

Jeschke MG, Barrow RE, Herndon DN.  Recombinant human growth hormone treatment in pediatric burn patients and its role during the hepatic acute phase response.  Crit Care Med 28:1578-1584, 2000.

3.486

0096

0343

Inpatient A

  111.     

Jeschke MG, Wolf SE, DebRoy MA, Herndon DN.  The combination of growth hormone with hepatocyte growth factor alters the acute phase response.  Shock 12:181-187, 1999.

2.157

0096

0343

Inpatient A

  112.     

Jeschke MG, Wolf SE, DebRoy MA, Jarrar D, Herndon DN.  Recombinant human growth hormone (rhGH) down-regulates hepatocyte growth factor (HGF) in burns.  J Surg Res 76:11-16, 1998.

1.663

0101

Outpatient A

  113.     

Johnson RW, Reveille JD, McNearney T, Fischbach M, Friedman AW, Ahn C, Arnett FC, Tan FK.  Lack of association of a functionally relevant single nucleotide polymorphism of matrix metalloproteinase-1 promoter with systemic sclerosis (scleroderma).  Genes & Immunity 2:273-275, 2001.

3.787

0256

Inpatient A

  114.     

Katner HP, Paar DP, Nadler JP, Jensen EH, Wilson HM, Finn TS, Petruschke RA, Zeldin RK.  Open-label study of a twice-daily indinavir 800-mg/ritonavir 200-mg regimen in HIV-infected adults failing a protease inhibitor regimen.  J Acquired Immune Deficiency Syndromes 31:483-7, 2002.

3.586

0342

Inpatient A

  115.     

Kent TA, Soukup VM, Fabian RH.  Heterogeneity affecting outcome from acute stroke: Making reperfusion worse.  Stroke 32:2318-2327, 2001.

5.300

0290

*Outpatient A

  116.     

Kholodnykh AI, Petrova IY, Larin KV, Motamedi M, Esenaliev RO. Precision of measurement of tissue optical properties with optical coherence tomography.  Appl Opt 42:3027-3037, 2003.

1.515

0103

Outpatient A

  117.     

Kietthubthew S, Hutcha S, Au WW.  Genetic and environmental interactions on oral cancer in southern Thailand.  Environ Mol Mutag 37:111-116, 2001.

2.276

0290

Outpatient A

  118.     

Kirill LV, Eledrisi MS, Motamedi M, Esenaliev RO. Noninvasive blood glucose monitoring with optical coherence tomography:  A pilot study in human subjects.  Diab Care 25:2263-2267, 2002 .

5.404

0096

0343

Inpatient A

  119.     

Klein GL, Herndon DN.  Magnesium deficit in major burns: Role in hypoparathyroidism and end-organ parathyroid hormone resistance.  Magnesium Res 11:103-109, 1998.

0.689

0096

Inpatient A

  120.     

Klein GL, Herndon DN.  The role of bone densitometry in the diagnosis and management of the severely burned patients with bone loss.  J Clin Densitometry 2:1-1-1-5, 1999.

1.928

0096

0343

Inpatient A

  121.     

Klein GL, Langman CB, Herndon DN.  Persistent hypopara-thyroidism following magnesium repletion in burn-injured children.  Pediatr Nephrol 14:301-304, 2000.

1.391

0096

0343

Inpatient A

  122.     

Klein GL, Wolf SE, Lang CB, Rosen CJ, Mohan S, Keenan BS, Matin S, Steffen C, Nicolai M, Sailer DE, Herndon DN.  Effect of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children following severe burn injury.  J Clin Endocrinol Metabol 8:21-24, 1998.

5.160

0096

0343

Inpatient A

  123.     

Klein GL, Langman CB, Herndon DN.  Vitamin D depletion following burn injury in children: A possible factor in post-burn osteopenia.  J Trauma-Injury Inf & Crit Care 52:346-350, 2002.

Not Available

0009

Outpatient A

  124.     

Koch R, Hanley W, Levy H, Matalon K, Matalon R, Rouse B, Trefz F, Güttler F, Azen C, Platt L, Waisbren S, Widaman K, Ning J, Friedman E, de la Cruz F.  The Maternal Phenylketonuria International Study: 1984-2002.  Pediatrics, Vol. 112: No. 6, 1523-1529, 2003.

3.416

0009

Outpatient A

  125.     

Koch R, Azen C, Friedman E, Hanley W, Levy H, Matalon R, Rouse B, Trefz F, Ning J, de la Cruz F.  Research Design, Organization, and Sample Characteristics of the Maternal PKU Collaborative Study.  Pediatrics 112:1519-1522, 2003.

 3.416

0009

Outpatient A

  126.     

Koch R, Hanley W, Levy H, Matalon R, Rouse B, Trefz F, Guttler F, Azen C, Friedman E, Platt L, de la Cruz F.  MINI REVIEW – Maternal PKU:  An international study.  Mol Gen Metabol 71:233-239, 2000.

 2.751

0009

Outpatient A

  127.     

Koch R, Friedman E, Azen C, Hanley W, Levy H, Matalon R, Rouse B, Trefz F, Waisbren SE, Michals-Matalon K, Acosta P, Guttler F, Ullrich K, Platt L, de la Cruz F.  The international collaborative study of maternal phenylketonuria status report 1998.  Mental Retard Devel Disabilities Res Rev 5:117-121, 1999.

 1.442

0073

0074

*Outpatient A

  128.     

Kohen F, Lichter S, Gayer B, Amir-Zaltsman Y, Ben-Hur H, Thomas E, Lu L-J.  A non-isotopic enzyme-based immunoassay for assessing human exposure to genistein.  Nutri and Canc 35:96-103, 1999.

 2.237

0073

Inpatient A

  129.     

Kohen F, Lichter S, Gayer, Deboever J, Lu, LJW.  The measurement of the isoflavone daidzein by time resolved fluorescent immunoassay - a method for assessment of dietary soya exposure.  J Steroid Biochem & Molecular Biol 64:217-222, 1998.

 2.544

0078

*Outpatient A

       130. .

Koutsari C, Sidossis LS.  Effect of isoenergetic low- and high-carbohydrate diets on substrate kinetics and oxidation in healthy men.  Brit J Nutr 90:413-418, 2003.

 2.491

0216

*Outpatient A

131.

Kuna ST.  Respiratory-related activation and mechanical effects of the pharyngeal constrictor muscles.  Respiratory Physiol 119:155-161, 2000.

 2.197

0296

Inpatient A

132.

Kunkel MM, Lorinczi M, Rijnbrand R, Lemon SM, Watowich J.  Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein.  J Virol 75:2119-2129, 2001.

 5.622

0096

0343

Inpatient A

133.

Lal S, Hart DW, Herndon DN.  Challenges of growth hormone therapy: Pros.  Curr Opin Clin Nutr Metab Care 3:135-138, 2000.

 Not Available

0096

0345

Inpatient A

134.

Lal SO, Herndon DN.  Recombinant human growth hormone to treat osteopenia and growth delay after major burns in children.  5^th World Congress on Trauma, Shock, Inflammation and Sepsis :859-861, 2000.

 Not Available

0096

0343

Inpatient A

135.

Lal SO, Wolf SE, Herndon DN.  Growth hormone, burns and tissue healing.  Growth Hormone & IGF Res Suppl B:S39-S43, 2000.

 1.253

0290

Outpatient A

136.

Larin KV, Ashitkov TV, Larina IV, Petrova IY, Eledrisi MS, Motamedi M, Esenaliev RO.  Optical coherence tomography technique for noninvasive blood glucose monitoring: Phantom, animal, and human studies.  SPIE Proc 4619 :157-164, 2002.

 Not Available

0290

Outpatient A

137.

Larin KV, Eledrisi MS, Ashitkov TV, Motamedi M, Esenaliev RO. Monitoring of tissue optical properties using OCT: Application for blood glucose analysis.  SPIE Proc 4707 :181-188, 2002.

 Not Available

0009

Outpatient A

 138.

Levy H, Guldberg P, Guttler F, Hanley WB, Matalon R, Rouse BM, Trefz F, Azen C, Allred E, de la Cruz F, Koch R.  Congenital heart disease in maternal phenylketonuria Report from the maternal PKU collaborative study.  Pediatr Res 49:636-642, 2001.

 3.289

0009

Outpatient A

 139.

Levy H, Waisbren S, Güttler F, Hanley WB, Matalon R, Rouse B, Trefz F, de la Cruz F, Azen C, Koch R, M.D.  Pregnancy Experiences in the Woman With Mild Hyperphenylalaninemia.  Pediatrics 112:1548-1552, 2003.

 3.416

0071

*Outpatient A

140.

Lieberman SA, Oberoi AL, Gilkison CR, Masel BE, Urban RJ.  Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury.  J Clin Endocrinol Metab 86:2752-2756, 2001

 5.160

0096

0343

Inpatient A

141.

Low JFA, Herndon DN, Barrow RE.  Effect of growth hormone on growth delay in burned children: A 3-year follow- up study.  Lancet 354:1789, 1999.

 13.251

0096

0343

Outpatient A

142.

Low JFA, Barrow RE, Mittendorfer B, Jeschke MG, Chinkes DL, Herndon DN.  The effect of short-term growth hormone treatment on growth and energy expenditure in burned children.  Burns 27:447-452, 2001.

 0.791

0074

Inpatient A

143.

Lu L-J W, Anderson K E, Nagamani M.  Chronic soy consumption influences serum levels of steroid and peptide hormones without uterine effects in postmenopausal women.  J Nutr 132:615S, 2002.

 3.246

0073

0074

*Outpatient A

144.

Lu L-J W, Anderson KE, Grady JJ, Nagamani M.  Effects of an isoflavone-free soy diet on ovarian hormones in premenopausal women.  J Clin Endocrinol Metabol 86:3045-3052,2001.

 5.160

0027

0073

0074

*Outpatient A

145.

Lu LJ, Anderson KE, Grady JJ, Kohen F, Nagamani M.  Decreased ovarian hormones but not gonadotropins during a soya diet: Implications for breast cancer prevention.  Cancer Res 60:4112-4121, 2000.

 8.302

0027

0074

*Outpatient A

146.

Lu LJ, Cree M, Josyula S, Nagamani M, Grady JJ, Anderson KE.  Increased urinary excretion of 2-hydroxyestrone but not 16 alphahyroxyestrone in premenopausal women during a soya diet containing isoflavones.  Cancer Res. 60:1299-1305, 2000.

 8.302

0073

0074

Inpatient A

       147.  

Lu L.-JW, Anderson KE.  Short half-lives and sex differences of excretion of soya isoflavones in humans.  Am J Clin Nutr 68:1500-1504S, 1998. 

(Note:  Title correction to Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans.)

 5.021

0073

0074

Inpatient A

       148.  

Lu L-JW, Tice J. Bellino F.  Phytoestrogens and healthy aging: gaps in knowledge (a workshop report).  Menopause 8:157-170, 2001.

 3.505

0033

Outpatient A

       149.  

Ma H, Smith DH, Abraham WH, Ward JB.  Multiplex polymerase chain reaction-based analysis of T-cell receptor y gene rearrangements for the determination of T-lymphocyte clonality.  Environ Molec Mutagen 35:1-8, 2000.

 2.276

0033

Outpatient A

       150.  

Ma H, Wood TG, Ammenheuser MM, Rosenblatt JI, Ward JB.  Molecular analysis of hprt mutant lymphocytes from1,3-butadiene-exposed workers. Environ Molec Mutagen 36:59-71, 2000.

 2.276

0243

*Outpatient A

       151.  

Maner WL, Garfield RE, Maul H, Olson G, Saade G.  Predicting term and preterm delivery with transabdominal uterine electromyography.  Obstet Gynecol 101:1254-60, 2003.

 2.482

0042

*Outpatient A

       152. 1

Masel BE, Scheibel RS, Kimbark T, Kuna ST.  Excessive daytime sleepiness in adults with brain injuries.  Arch of Phys Med & Rehab 82:1526-1532, 2001.

 1.371

0009

Outpatient A

       153. .

Matalon KM, Acosta P, Azen C, Matalon R.  Congenital heart disease in maternal phenylketonuria: Effects of blood phenylalanine and nutrient intake.  Ment Retard Devel Disabilities Res Rev 5:122-124, 1999.

 1.442

0243

*Outpatient A

       154.  

Maul H, Olson G, Fittkow CT, Saade GR, Garfield RE.  Cervical light-induced fluorescence in humans decreases throughout gestation and before delivery: Preliminary observations.  Am J Obstet Gynecol 188:537-541, 2003.

 2.556

0243

*Outpatient A

       155.  

Maul H, Maner WL, Saade GR, Garfield RE.  The physiology of uterine contractions.  Clin Perinatol 30:665-676v, 2003.

 1.417

0072

Inpatient A

       156.  

Mauras N, Hayes V, Welch S, Rini A, Helgeson K, Dokler M, Veldhuis JD, Urban RJ.  Testosterone deficiency in young men: Marked alterations in whole body protein kinetics, strength, and adiposity.  J Clin Endocrinol Metab 83:1886-1892, 1998.

 5.160

0261

Outpatient A

       157.  

McCormick D, Saeed K, Baldwin C, Chonmaitree T, Friedman N.  Quantifying the severity of acute otitis media: Measures of parent perceptions.  J Invest Med 49:145A, 2001.

 2.527

0082

0261

Outpatient A

       158.  

McCormick DP, Friedman N, Chonmaitree T, Saeed K, Baldwin CD, Klimisch T.  Acute otitis media (AOM) part 1 & 2: Relation between appearance of the tympanic membrane ™ and parent perception of illness.  J Invest Med 50:144A, 2002.

 2.527

0261

*Outpatient A

       159.  

McCormick DP, Saeed KA,Pittman C, Baldwin CD, Friedman N, Teichgraeber DC, Chonmaitree T. Bullous myringitis: a case-control study. Pediatrics 112:982-986, 2003.

 3.416

0261

*Outpatient A

       160.  

McCormick DP, Saeed K, Uchida T, Baldwin CD, Deskin R, Lett-Brown MA, Heikkinen T, Chonmaitree T.  Middle ear fluid histamine and leukotriene B4 in acute otitis media: effect of antihistamine or corticosteroid treatment.  Int J Pediatr Otorhinolaryngol 67:221-230, 2003.

 0.613

0082

0261

*Outpatient A

       161.  

McCormick DP, Lim-Melia E., Saeed KA, Baldwin CD, Chonmaitree T.  Otitis media: Can clinical findings predict bacterial or viral etiology?  Ped Infect Dis J 19:256-258, 2000.

 2.289

0261

Outpatient A

       162. .

McCormick DP, Uchida T.  Tobacco smoke, day care, middle-ear surgery, and costs in young children.  J Invest Med 47:129a, 1999.

 2.527

0101

0257

*Outpatient A

       163.  

McNearney T, Lin X, Shrestha J, Lisse J, Chen JD.  Characterization of gastric myoelectrical rhythms in patients with systemic sclerosis using multichannel surface electrogastrography.  Dig Dis Sci 47 :690-8, 2002.

 2.527

0255

*Outpatient A

       164.  

Meyer WJ, Blakeney P, Russell W, Thomas C, Robert R, Berniger F, Holzer C.  Psychological problems reported by young adults who were burned as children, Shriners Hospitals for Children, Galveston Burns Hospital.  J Burn Care Rehabil 2004.  Accepted 08/01/2003.

 0.974

0260

*Inpatient A

Outpatient A

       165.  

Miller SL, Tipton KD, Chinkes DL, Wolf SE, Wolfe RR.  Independent and combined effects of amino acids and glucose on muscle protein following exercise.  Med Sci Sports Exerc 35:449-455, 2003.

 2.600

0229

Inpatient A

       166.  

Miller SL, Wolfe RR.  Physical exercise as a modulator of adaptation to low and high carbohydrate and low and high fat intakes.  Euro J of Clinical Nutri 53S1:S112-S119, 1999.

 1.765

0010

*Inpatient A

Outpatient A

       167.  

Mittendorfer B, E Volpi, RR Wolfe.  Whole-body and skeletal muscle glutamine metabolism in healthy subjects.  Am J Physiol Endocrionol Metab 280:E323-E333, 2001.

 3.324

0035

Inpatient A

       168.  

Mittendorfer B, Sidossis LS, Walser E, Chinkes DL, Wolfe RR.  Regional acetate kinetics and oxidation in human volunteers.  Am J Physiol (Endocrinol Metab 35)274:E978-E983, 1998.

 3.324

0103

Outpatient A

       169.  

Moore TO, Yen-Moore A, Carrasco D, Straten MV, Arany I, Au WW, Tyring S.  Human papillomavirus, smoking and cancer.  J Cutan Med Surg 5:323-328, 2001.

 Not Available

0002

Inpatient A

       170.  

Nagamani M, Urban RJ.  Increased expression of messenger ribonucleic acid encoding cytochrome P450 cholesterol side-chain cleavage and P450 17alpha-hydroxylase enzymes in ovarian hyperthecosis.  Fertility & Sterility 71:328-333, 1999.

2.960

0084

*Outpatient A

       171.  

Nokta MA, Li XD, Nichols J, Mallen M, Pou A, Asmuth D, Pollard RB.  Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV infected individuals.  AIDS 15:161-169, 2001.

 6.881

0084

0246

*Outpatient A

       172.  

Nokta MA, LI XD, Nichols J, Pou An Asmuth D, Pollard RB.  Homeostasis of naive memory T cell subpopulations in lymphoid tissues in the contest of human immunodeficiency virus infection.  J Infect Dis 183:1336-1342, 2001.

 4.910

0285

0312

Outpatient A

       173.  

Ouyang H, Yin J, Wang Z, Pasricha PJ, Chen JDZ.  Electro-acupuncture accelerates gastric emptying in association with changes in vagal activity.  Am J Physiol Gastrointest Liver Physiol 282:G390-G396, 2002.

 3.660

0262

*Inpatient A

Outpatient A

       174.  

Paddon-Jones D, Wolfe RR, Ferrando AA.  Amino acid supplementation for reversing bedrest and steroid myopathies. J Nutr 2004. Accepted 11/01/2003.

 3.620

0267

*Inpatient A

Outpatient A

       175.  

Paddon-Jones D, Sheffield-Moore M, Creson DL, Sanford AP, Wolf SE, Wolfe RR, Ferrando AA.  Hypercortisolemia alters muscle protein anabolism following ingestion of essential amino acids.  Am J Physiol Endocrinol Metab 284:E946-E953, 2003.

 3.620

0267

*Inpatient A

Outpatient A

       176.  

Paddon-Jones D, Sheffield-Moore M, Zhang XJ, Volpi E, Wolf SE, Aarsland A, Ferrando AA, Wolfe RR.  Amino acid ingestion improves muscle protein synthesis in the young and elderly.  Am J Physiol Endocrinol Metab 286:E321-E328, 2003.

3.620

0267

Inpatient A

       177.  

Paddon-Jones D, Abernethy P.  Acute adaptation to low volume eccentric exercise.  Med. Sci. Sports Exerc 33 :1213-1219, 2001.

 2.402

0267

Inpatient A

       178.  

Paddon-Jones D, Keech A, Jenkins D.  Short-term ß-hydroxy-ß-methylbutyrate supplementation does not reduce symptoms of eccentric muscle damage.  Int J Sports Nutr 11 :442-450, 2001.

 1.225

0111

Inpatient A

       179.  

Phillips SM, Tipton KD, Ferrando AA, Wolfe RR.  Resistance training reduces the acute exercise-induced increase in muscle protein turnover.  Am J Physiol Endocrionol Metab 276:E118-E124, 1999.

 3.324

0299

Inpatient A

       180.  

Phillips SM, Parise G, Roy BD, Tipton KD, Wolfe RR, Tarnopolsky MA.  Resistance training-induced adaptations in skeletal muscle protein turnover in the fed state.  Can J Physiol Pharmacol 80:1045-1053, 2002.

 1.261

0009

Outpatient A

       181.  

Platt LD, Koch R, Hanley WB, Levy HL, Matalon R, Rouse B, Trefz F, de la Cruz F, Guttler F, Azen C, Friedman EG.  The international survey of pregnancy outcome in women with maternal phenylketonuria: report of a 12-year study.  Am J Obstet Gynecol 182:326-333, 2000.

 2.871

0037

0203

0018

*Inpatient A

Outpatient A

       182.  

Poh-Fitzpatrick MB, Wang X, Anderson KE, Bloomer JR, Bolwell B, Lichtin AE.  Erythropoietic protoporphyria: Altered phenotype after bone marrow transplantation for myelogenous leukemia in a patient heteroallelic for ferrochelatase gene mutations.  J Am Acad Dermatol 46:861-866, 2002.

 2.341